MeSH Browser

MeSH Heading: Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
Tree Number(s): D02.705.429.906.125; D03.383.533.375; D03.383.742.680.245.500.600.125; D03.633.100.759.138.881.125; D26.310.375
Unique ID: D000068257
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D000068257
Scope Note: Inhibitor of reverse transcriptases or of RNA-directed DNA polymerases.
Entry Term(s): Atripla
Pharm Action: Reverse Transcriptase Inhibitors
Anti-HIV Agents
Registry Number: 0
See Also: Antiretroviral Therapy, Highly Active
Public MeSH Note: 2016; Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination was indexed under ADENINE 2007-2015, under DEOXYCYTIDINE 2007-2015, under OXAZINES 2007-2015, under ORGANOPHOSPHATES 2007-2015, and under DRUG COMBINATIONS 2007-2015
History Note: 2016 (2007)
Date Established: 2016/01/01
Date of Entry: 2015/07/10
Revision Date: 2019/04/29

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

analysis (AN)

antagonists & inhibitors (AI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination MeSH Descriptor Data 2024